BB&T Securities’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
DSA
MWNA
BB&T Securities's DGX Position: Q3 2019 in Review
BB&T Securities reduced its Quest Diagnostics (DGX) stake by 43% in Q3 2019, selling an estimated $533K and leaving 6,964 shares worth $745K. The position accounts for 0.01% of the portfolio, ranked #930.
BB&T Securities first reported a position in DGX in Q1 2015 and has held it in 19 quarters since. The position peaked at $1.24M in Q2 2019. 677 funds tracked by Wall St. Rank hold DGX as of Q3 2019.
- BB&T Securities held 6,964 shares of Quest Diagnostics worth $745K as of Q3 2019.
- BB&T Securities sold 5,193 Quest Diagnostics shares in Q3 2019, an estimated $533K.
- Quest Diagnostics made up 0.01% of BB&T Securities's portfolio in Q3 2019, its #930 holding.
- BB&T Securities first reported a position in Quest Diagnostics in Q1 2015 and has held it in 19 quarters since.
- BB&T Securities's Quest Diagnostics position peaked at $1.24M in Q2 2019.
- 677 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2019.
Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.